Mostrando 3 resultados de: 3
Filtros aplicados
Área temáticas
Enfermedades(2)
Cirugía y especialidades médicas afines(1)
Funcionamiento de bibliotecas y archivos(1)
Medicina y salud(1)
Área de conocimiento
Medicina interna(1)
Origen
scopus(3)
Editorial commentary on: “Reduced vs full-dose BCG therapy in bladder cancer: A systematic review and meta-analysis”
OtherAbstract:Palabras claves:Autores:del Giudice F., Diego M. Carrión, Moschini M., Pradere B., Soria F.Fuentes:scopusIdentifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer
ArticleAbstract: Purpose:We investigated the pathological response rates and survival associated with 3 vs 4 cycles oPalabras claves:drug administration schedule, neoadjuvant therapy, Survival, urinary bladder neoplasmsAutores:Barocas D.A., Bivalacqua T.J., Black P.C., Cookson M.S., Dall'Era M.A., Daneshmand S., Di Trapani E., Diego M. Carrión, Dinney C.P., D’Andrea D., Grivas P.D., Holzbeierlein J.M., Kassouf W., Lotan Y., McGrath J.S., Montgomery J.S., North S., Shariat S.F., Soria F., Spiess P.E., Sridhar S.S., Stephenson A.J., Thorpe A.C., van Rhijn B.W.G., Wright J.L., Zargar H.Fuentes:scopusThe Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
ArticleAbstract: Background: There might be differential sensitivity to neoadjuvant chemotherapy (NAC) in patients wiPalabras claves:bladder cancer, Neoadjuvant chemotherapy, Primary, Response, Secondary, SurvivalAutores:Alvarez-Maestro M., Brönimann S., De Berardinis E., del Giudice F., Di Maida F., Di Trapani E., Diego M. Carrión, D’Andrea D., Filippot R., Grisay G., Hendricksen K., Krajewski W., Laukhtina E., Maggi M., Mari A., Mertens L.S., Moschini M., Paulnsteiner D., Pichler R., Pradere B., Shariat S.F., Soria F., Vallet S., van Rhijn B.W.G.Fuentes:scopus